Synageva BioPharma Corp. (NASDAQ: GEVA)

 
SEC Filings
Date Filed Filing Description View
Apr 17, 2015 4 quinn, anthony HTML PDF XLS
 
Apr 14, 2015 PRE 14A preliminary proxy statement HTML PDF XLS
 
Apr 9, 2015 4 williams, glen HTML PDF XLS
 
Apr 8, 2015 4 quinn, anthony HTML PDF XLS
 
Mar 13, 2015 4 heberlig, chris HTML PDF XLS
 
Feb 26, 2015 10-K annual report HTML PDF XLS XBRL
Feb 26, 2015 8-K current report HTML PDF XLS
 
Feb 19, 2015 4 boess, carsten HTML PDF XLS
 
Feb 13, 2015 SC 13G/A amended statement of beneficial ownership HTML PDF XLS
 
Feb 13, 2015 SC 13G/A amended statement of beneficial ownership HTML PDF XLS
 
1
...
NextLast